Maspin Peptides Enhance Cell Adhesion to Inhibit Cancer Motility

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cancer treatments lack effective methods to inhibit tumor cell motility and metastasis, as existing therapies fail to enhance cell adhesion, a crucial mechanism in preventing cancer spread.

Innovation Solution

Administration of maspin-related proteins or peptides with at least 70% sequence identity to wild-type or mutant maspin, which physically associate with uPAR and β1 integrin, enhancing cell adhesion and inhibiting cell motility by localizing at the cell surface and interacting with the uPA/uPAR complex.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If existing cancer therapies are used, then general cancer treatment is provided, but they fail to enhance cell adhesion and inhibit tumor cell motility

Engineering Contradiction:
Improveeffectiveness in inhibiting tumor cell motilityVSAvoidability to enhance cell adhesion
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The invention extracts and utilizes specific maspin peptides (such as those corresponding to amino acid residues 190-202 and 260-275) that contain the adhesion-enhancing and motility-inhibiting functions, separating these functional elements from the full-length maspin protein to create targeted therapeutic compositions

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention changes the molecular parameters by using truncated peptide versions of maspin rather than the full-length protein, demonstrating that specific regions (particularly those with at least 70% sequence identity to wild-type or mutant maspin) retain and concentrate the therapeutic functions of enhancing cell adhesion and inhibiting cell motility

Inventive Principle:
Principle #35Parameter changes

2Reliability

If maspin-related peptides are administered, then cell adhesion is enhanced and cell motility is inhibited, but the mechanism requires physical association with uPAR and β1 integrin

Engineering Contradiction:
Improvecell adhesion enhancementVSAvoidinteraction mechanism complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The maspin peptides act as intermediary molecules that physically associate with uPAR and β1 integrin on the cell surface, mediating the enhancement of cell adhesion and inhibition of cell motility through these specific protein-protein interactions

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS8791233B2Maspin-based peptides and methods of use thereof
Publication Date: 2014.07.29 NORTHWESTERN UNIV
  • US8791233B2 patent drawing
  • US8791233B2 patent drawing
  • US8791233B2 patent drawing

AI summary

The present invention provides maspin-related compositions and methods of use thereof. In particular, the present invention provides maspin-related compositions, and methods or use thereof, for the promotion of cell adhesion.